Industrial Securities(SH:601377) Zheng Quan Zhi Xing·2025-09-04 16:18Core Viewpoint - The company has decided to postpone the completion date of the "Apple Acid Co-production Tryptophan Project" from 2025 to October 2026 due to actual construction progress and investment considerations [5][6][7]. Fundraising and Investment Project Overview - The company has successfully raised a net amount of RMB 683.81 million after deducting issuance costs of RMB 16.19 million, with all funds received by October 21, 2024 [1][2]. - The adjusted fundraising allocation for investment projects totals RMB 683.81 million, down from an initial plan of RMB 700 million [2][3]. Fund Usage and Project Status - As of June 30, 2025, the company has fully utilized the raised funds for the "Apple Acid Co-production Tryptophan Project" and the "Succinic Acid Co-production Valine/Inositol Project," with investment ratios exceeding 100% for both projects [5][6]. - The company has established a special account for the management of raised funds, ensuring compliance with regulatory requirements [2][3]. Delay Details - The postponement of the "Apple Acid Co-production Tryptophan Project" is based on market demand and technical upgrades to production equipment, with no changes to the project's investment direction or implementation [6][7]. - The company has confirmed that the delay will not adversely affect the normal operation of the company or the interests of shareholders, particularly minority investors [8]. Approval and Oversight - The decision to postpone the project has been approved by the company's board and supervisory committee, adhering to necessary regulatory procedures [8][9]. - The sponsor institution has conducted a thorough review and supports the decision, confirming that it aligns with relevant laws and regulations [8][9].